Centre for Genomic Regulation

Rhythm Of Oscillations In Cerebral Cortex, Key To Understanding Down Syndrome

Article
Brain & Nerve
Current Medical News
+1
Contributed byMaulik P. Purohit MD MPHApr 14, 2016

Cerebral activity is governed by a fine balance between neuronal excitation and inhibition. Specifically, neurons are activated by excitation mechanisms tightly regulated by inhibition processes. For certain functions, the neuronal network needs to be synchronized. This causes high-frequency oscillations that make behavior and information-processing possible. This synchronization depends on the excitation/inhibition balance that is affected in a significant number of disorders that involve cognitive dysfunction.

In an article published in the current issue of the Journal of Neuroscience, scientists from the Centre for Genomic Regulation, led by Dr. Mara Dierssen, and the laboratory of Dr. Mavi Sánchez Vives, at the Biomedical Research Institute (IDIBAPS), describe altered oscillations and synchronization in the cerebral cortex for a Down syndrome candidate gene in a mouse model. Such alterations have been linked to problems with functions as relevant as decision-making, impulsiveness, working memory or attention.

"Changes in the cellular architecture of neurons in the cerebral cortex, in Down syndrome animal models had already been detected in the past. We observed that the neurons had a different structure. Now we have taken another step, studying the physiology, or the function of this cerebral cortex, and found that those cellular alterations and slight changes in inhibitory connectivity translate into a deficit of activation of this region and of its neuronal activity rhythm and synchronization," states Dr. Mara Dierssen, head of the Cellular and Systems Neurobiology group and Co-Principal Investigator of this study. "One of the main problems with mental impairment is that we don't understand how the alterations that we detect at the cellular level trigger changes in the cerebral circuits and alterations in cognitive function. The study that we've published explains some of these cellular alterations and offers for the first time an in vivo study of the physiology of the cerebral cortex, a key structure in executive functions such as concentration, learning or problem-solving." she adds.

The researchers focused on one of the genes related with Down syndrome. Using experiments on animal models that overexpress the candidate gene, the researchers have shown that an excess of this gene causes very subtle changes in the excitation/inhibition balance, and these lead to a significant diminishment of the activity and synchronization of excitatory neurons in the prefrontal cortex. In other words, when this gene is over-expressed, it reduces the discharge level of the neurons and alters the oscillation of high-frequency waves in the cerebral cortex. Not only that, they observed that the problem originates in neurons responsible for controlling inhibition. In short, if there is less activity and an imbalance in the frequencies of the cerebral waves in Down syndrome it could be due to changes in the connectivity of neurons that should control them.

The study combined experiments in electrophysiology and histology with a computational model that virtually emulates the neuronal circuit of the cerebral cortex. "We've identified anatomical and functional alterations and, using a computational model, we've shown how these deficits could explain experimental observations," says Dr. Sánchez Vives, head of the Systems Neurosciences team and Co-Principal Investigador of this paper. "The computational model has made it possible for us to understand the entire mechanism. We can make predictions on how the cerebral cortex functions in this pathology, and how the alterations detected will impact cognitive function," concludes the researcher.



The above post is reprinted from materials provided by Centre for Genomic RegulationNote: Materials may be edited for content and length.

Disclaimer: DoveMed is not responsible for the adapted accuracy of news releases posted to DoveMed by contributing universities and institutions.

Primary Resource:

Ruiz-Mejias, M., de Lagran, M. M., Mattia, M., Castano-Prat, P., Perez-Mendez, L., Ciria-Suarez, L., ... & Delgado-García, J. M. (2016). Overexpression of Dyrk1A, a Down Syndrome Candidate, Decreases Excitability and Impairs Gamma Oscillations in the Prefrontal Cortex. The Journal of Neuroscience36(13), 3648-3659.

Was this article helpful

On the Article

Maulik P. Purohit MD MPH picture
Approved by

Maulik P. Purohit MD MPH

Assistant Medical Director, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!